Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 02, 2016
CluePoints, a provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM) solutions for clinical trials, has announced a new Data Quality Oversight service, RADARTM, aimed at helping sponsors achieve a data-driven ...
read more
Tuesday, November 01, 2016
Veristat, a full service consultative Clinical Research Organization (CRO), has announced the formal launch of its Strategic Decision Consulting service offering to help pharmaceutical, biotechnology and medical device firms solve the unique and ...
read more
Epizyme, Inc. has entered into two Cooperative Research and Development Agreements (CRADAs) with the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI). The CRADAs will evaluate tazemetostat, Epizyme’s first-in-class EZH2...
read more
Imprimis Pharmaceuticals has filed for registration of its recently-constructed New Jersey facility with the U.S. Food and Drug Administration (FDA) as a 503B outsourcing facility. The state-of-the-art facility is expected to begin manufacturing as ...
read more
Thursday, October 27, 2016
Life sciences companies increasingly are seeking new models to connect expanding sets of disparate, non-identified patient-level data streams to better develop and commercialize next-generation medicines. The need for practical, evidence-based ...
read more
Thursday, October 27, 2016
Evotec AG has made an offer to acquire Cyprotex PLC, a specialist pre-clinical contract research organization in ADME-Tox and DMPK. Cyprotex serves the industry's increasing requirement for earlier drug screening, regulatory requirements and reducing...
read more
Thursday, October 27, 2016
ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has further improved its feasibility, protocol optimization and patient recruitment ...
read more
Thursday, October 27, 2016
BioStorage Technologies, Inc. a provider of comprehensive sample lifecycle management for the life sciences industry and subsidiary of Brooks Life Science Systems, has announced the expansion of its sample storage services in the U.S. and ...
read more
Wednesday, October 26, 2016
Daiichi Sankyo, Inc. and Inspirion Delivery Sciences LLC (Inspirion) announced today that the companies have entered into a strategic collaboration agreement in the U.S. to commercialize FDA-approved MorphaBond™ (morphine sulfate) extended-release ...
read more
Wednesday, October 26, 2016
Heat Biologics a developer of gp96-based immunotherapies that activate a patient’s immune system to fight cancer, announced that it has entered into an agreement with the University of Miami for the license and development of a portfolio of patents ...
read more
Wednesday, October 26, 2016
Oxford Genetics Ltd, a biotech company which specializes in DNA design, protein expression optimization and cell line development technologies and services, has moved its operations to new state-of-the-art laboratories at The Oxford Science Park.
read more
Wednesday, October 26, 2016
After one year of construction and a month to fine-tune new equipment, Ashland put on display its Pharmaceutical Technical Center in Shanghai, formally opening the facility following a major upgrade. The state-of-the-art complex now accommodates all ...
read more
Wednesday, October 26, 2016
Eisai Inc. and the Oklahoma Medical Research Foundation (OMRF) have formed a research collaboration to study the autoimmune disease lupus.
read more
Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced the appointment of Kunal Jaiswal to the role of Vice President, Strategic ...
read more
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has announced that, as part of its planned succession of executive leadership, Mr. Ciaran Murray will ...
read more